Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|April 27, 2004
Role of E2F1 in apoptosis: a case study in feedback loopsDejan Knezevic, Douglas E BrashProceedings of the National Academy of Sciences of the United States of America|June 26, 2007
Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signalingDejan Knezevic, Wengeng Zhang, Patrick J Rochette, et al.Cell Cycle (Georgetown, Tex.)|June 4, 2008
Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradationMingxuan Xia, Dejan Knezevic, Christian Tovar, et al.Food Research International (Ottawa, Ont.)|February 22, 2025
Application of R-phycoerythrin of different purities from Furcellaria lumbricalis in extruded food productsSruthi Kumar, Sara M Gaber, Dejan Knezevic, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2006
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1Lyubomir T Vassilev, Christian Tovar, Shaoqing Chen, et al.Nature Cell Biology|July 2, 2003
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient miceNorbert M Wikonkal, Eva Remenyik, Dejan Knezevic, et al.Urology|August 25, 2018
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN StatusCristina Magi-Galluzzi, Sudhir Isharwal, Sara M Falzarano, et al.Oncotarget|April 29, 2016
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effectCristina Magi-Galluzzi, Tara Maddala, Sara Moscovita Falzarano, et al.The Journal of Urology|January 25, 2021
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate CancerJennifer Cullen, Julie A Lynch, Eric A Klein, et al.BMC Genomics|October 10, 2013
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsiesDejan Knezevic, Audrey D Goddard, Nisha Natraj, et al.Pageof 2